Bird & Bird advised Moon Surgical on its new round. GT Healthcare Capital & Partners, Cathay Health and Johnson & Johnson Innovation were advised by Goodwin....
Moon Surgical’s EUR55.4 Million Fundraising
Graneet’s 8 Million Serie A Fundraising
Bird & Bird advised Graneet on its Series A round. French start-up Graneet has raised €8 million in a second round of Series A funding for...
Exotrail’s EUR 58 Million Series B Fundraising
Eurazeo Investment Manager and Bpifrance Investissement (for Sociétés de Projets Industriels 2 and Fonds Innovation Défense) were advised by Alérion Avocats. CELAD was advised by Kopper....
H2 Mobility’s €110 Million Financing Round
Noerr advised H2 MOBILITY Deutschland on the deal. Bird & Bird advised Hy24. H2 MOBILITY Deutschland announced a round of financing worth €110m and the entry of...
Technip Energies’ Strategic Investment in Hy2gen AG
Clifford Chance advised Technip Energies NV on the deal while Jones Day advised Caisse de dépôt et placement du Québec (CDPQ). Bird & Bird advised Hy24...
Vestiaire Collective’s €178 Million Funding Round
Dechert advised Vestiaire Collective in the transaction. J&A advised Balderton, Bpifrance Investissement, Condé Nast, Eurazeo growth, Fidelity International, Idinvest, Kering Venture, Korelya Capital, Tiger, Ventech and...
ISAI and Sagard NewGen’s Acquisition of a Majority Stake in Invoke
KPMG Avocats advised ISAI and Sagard NewGen, while Dechert advised Stéphane Allez and Rémi Lacour, founders of Invoke. Invoke completed its takeover by the funds ISAI Expansion...
Shift Technology’s USD220 Million Series D Funding Round
Dechert advised Shift Technology, while Gide Loyrette Nouel advised Accel, Bessemer Venture Partners, General Catalyst and Iris Capital on the deal. Jones Day advised Bpifrance. Shift...
Filippo Monteleone and Domnin de Kerdaniel’s Acquisition of Essling Capital
Scotto Partners and Dechert advised Filippo Monteleone and Domnin de Kerdaniel on the deal. Domnin de KERDANIEL (CVC Capital Partners, 3i, KKR) and Filippo MONTELEONE, Founding...
Olgram’s €1,5 Million Funding
Dechert advised Olgram on the deal. Olgram, a French biotech company that develops algae-based anti-infectives, completed its €1.5 million fundraising. The investors include bpifrance, the Brittany...